Efficacy and safety of immune checkpoint inhibitors in advanced non-small cell lung cancer with idiopathic interstitial pneumonia or interstitial lung abnormalities: NJLCG2301
免疫检查点抑制剂治疗伴有特发性间质性肺炎或间质性肺异常的晚期非小细胞肺癌的疗效和安全性:NJLCG2301
期刊:Translational Lung Cancer Research
影响因子:3.5
doi:10.21037/tlcr-2025-783
Okumura, Fumihiko; Tanaka, Hisashi; Onodera, Katsuhiro; Morita, Ryo; Inomata, Minehiko; Suzuki, Aya; Sugisaka, Jun; Minemura, Hiroyuki; Jingu, Daisuke; Kudo, Satoshi; Kikuchi, Hajime; Yoshimura, Naruo; Tsushima, Fumiyasu; Kakeda, Shingo; Tasaka, Sadatomo